何时、如何及对谁进行治疗药物监测
本文综述炎症性肠病治疗药物监测(TDM)的演进,从单纯测药浓度到依据靶浓度主动优化剂量。反应性TDM在抗TNF抗体中广泛应用,其他单抗数据较少;主动调整生物制剂剂量以预防失应答是趋势。文章还总结药物浓度与抗药抗体检测方法及TDM算法路径。
要点
- 反应性TDM在抗TNF抗体失应答时应用广泛,其他类别单抗证据较少。
- 主动调整生物制剂剂量以预防失应答符合tight control理念。
- TDM需结合药物浓度与抗药抗体检测及算法化路径。
核心结论
- TDM已从单纯测药浓度演进为依据靶浓度主动优化剂量,反应性TDM广泛用于抗TNF抗体,其他单抗数据较少。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- 反应性TDM在失应答时检测已被实践广泛接受,尤其针对抗TNF抗体。
- 主动调整生物制剂剂量以预防失应答是TDM发展趋势,符合tight control理念。
- 其他类别单抗的反应性TDM数据较少。
临床怎么用
- 抗TNF抗体失应答时可进行反应性TDM指导剂量优化。
- 可依据靶浓度主动调整生物制剂剂量以预防失应答。
- TDM应结合药物浓度与抗药抗体检测及算法化路径。
局限性
- 其他类别单抗的TDM数据较少。
- 药代动力学原则未来应用仍需未满足需求与必要研究支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The implementation of therapeutic drug monitoring (TDM) in the inflammatory bowel disease practice has evolved over the years. In the early days, the focus was merely on measuring and reporting drug concentrations. Later, these concentrations were considered in light of target concentrations that are related to clinical response. This not only allowed passively predicting a patient's future response, but it also triggered physicians and pharmacists to actively use the information to optimize the drug dosage to induce and maintain a clinical response in the future. Although reactive TDM, testing at time of loss of response, is widely accepted in practice, especially for anti-tumor necrosis factor antibodies, there are less data for the other monoclonal antibodies belonging to other classes. Besides reactive testing, there is a movement toward proactively adjusting biologic dosing to prevent loss of response, in keeping with the tight control philosophy of inflammatory bowel disease care. This review highlights the various assays available to measure drug concentrations and antidrug antibodies, as well as algorithmic approaches to TDM, the unmet needs and required studies to enable pharmacokinetics principles to be applied in the future.
引用
- Vermeire S, Dreesen E, Papamichael K, et al. How, When, and for Whom Should We Perform Therapeutic Drug Monitoring? Clin Gastroenterol Hepatol. 2019. PMID: 31589978. doi:10.1016/j.cgh.2019.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。